search
Back to results

Sirius in Gynaecological Laparoscopic Surgery

Primary Purpose

Ovarian Cancer, Cervical Cancer, Gynecologic Cancer

Status
Recruiting
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Gynaecological laparoscopic surgery (Sirius System)
Sponsored by
Precision Robotics (Hong Kong) Limited
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ovarian Cancer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

Eligible women, 18 or older, who are planned for laparoscopic gynaecological surgery and willing to provide informed consent prior to surgery

Exclusion Criteria:

  1. Patient is pregnant, or planning on becoming pregnant
  2. Obese patients (BMI >35)
  3. Patient with known contraindication(s) to Laparoscopic Gynecological Surgery
  4. Patient with operations planned for longer than 4 hours
  5. Subjects are considered ineligible for the study as judged by the investigator.

Sites / Locations

  • Gleneagles Hospital Hong KongRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Gynaecological laparoscopic surgery

Arm Description

Eligible women aged 18 - 70 years, regardless of parity, who need laparoscopic gynaecological surgery and who provide informed consent prior to surgery

Outcomes

Primary Outcome Measures

To evaluate the Performance and Safety of the SIRIUS Endoscope System articulated tip.
The performance and safety of the endoscope system will be evaluated based on the outcome of the operation, in terms of patient blood lost and duration of the operation are comparable with the use of other conventional endoscope systems.

Secondary Outcome Measures

To assess the amount of time of straight and bending positions of SIRIUS Endoscope System articulated tip. To evaluate the events of device deficiency and/or malfunctions of SIRIUS Endoscope System. To evaluate the Safety of SIRIUS Endoscope System
To assess the effectiveness of the bending function of the SIRIUS endoscope system by capturing the amount of time the SIRIUS endoscope is bent or straightened during the operation.

Full Information

First Posted
September 8, 2021
Last Updated
October 2, 2022
Sponsor
Precision Robotics (Hong Kong) Limited
Collaborators
Gleneagles Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05048407
Brief Title
Sirius in Gynaecological Laparoscopic Surgery
Official Title
A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 3, 2022 (Anticipated)
Primary Completion Date
January 14, 2023 (Anticipated)
Study Completion Date
January 14, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Precision Robotics (Hong Kong) Limited
Collaborators
Gleneagles Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
Precision Robotics' Sirius Robotic Flexible Endoscopic System is a new fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing direction. A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. The study is a single-arm prospective study to evaluate the Performance and Safety of the SIRIUS Endoscope System.
Detailed Description
Minimally invasive surgery (MIS) is well established in gynecological surgery. Compared to laparotomy, MIS is associated with reduced morbidity and quicker recovery. With advancement in laparoscopic technology and techniques, MIS in gynecology has progressed from multi-port to single incision laparoscopic surgery (SILS) and vaginal natural orifice transluminal endoscopic surgery (vNOTEs), thus further reducing morbidity and enhancing recovery. One of the challenges of MIS is the restriction of the range of surgical movement. To overcome these technical challenges, articulated instruments are increasingly being used. The SIRIUS Endoscope System is a new, fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing direction. The articulated tip has three degrees of freedom, enabling C and S-shaped bending, and providing a wider field of view compared to conventional laparoscopes. This wider field of view is of advantage for SILS and vNOTEs. Presently available commercial systems do not have the same field of view or degrees of freedom. A first in-human, proof of concept, and early development study of the SIRIUS Endoscope System was done at GHK in 2021 (HKU-GHK IRB 2021-01, ClinicalTrials.gov NCT05048407). The successful completion of 11 of 13 (85%) planned procedures in this sequentially reported, prospective case series, shows that the SIRIUS Endoscope System can be used with indications of safety, and efficacy for intermediate and major MIS laparoscopic procedures in gynecology. The findings have been submitted for consideration for publication. Based on the outcome of this study, further improvements to the SIRIUS Endoscope System have been made to enhance safety, reliability, and usability. This proposed prospective study is a confirmatory study to evaluate the performance and safety of the SIRIUS Endoscope System in preparation for regulatory approval.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ovarian Cancer, Cervical Cancer, Gynecologic Cancer

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Gynaecological laparoscopic surgery
Arm Type
Experimental
Arm Description
Eligible women aged 18 - 70 years, regardless of parity, who need laparoscopic gynaecological surgery and who provide informed consent prior to surgery
Intervention Type
Device
Intervention Name(s)
Gynaecological laparoscopic surgery (Sirius System)
Intervention Description
The laparoscopic procedures were done in the usual manner. The only difference was for the study participants, the Sirius System was used in place of the usual conventional laparoscope. All other procedures and instruments including the number of ports remained the same. For every procedure using the Sirius System, a conventional laparoscope was on immediate standby to replace the Sirius System should there be an unanticipated equipment failure so that the procedure could be completed without delay.
Primary Outcome Measure Information:
Title
To evaluate the Performance and Safety of the SIRIUS Endoscope System articulated tip.
Description
The performance and safety of the endoscope system will be evaluated based on the outcome of the operation, in terms of patient blood lost and duration of the operation are comparable with the use of other conventional endoscope systems.
Time Frame
Data will be collected during the operation and the analysis will be completed up to 1 month post-operation
Secondary Outcome Measure Information:
Title
To assess the amount of time of straight and bending positions of SIRIUS Endoscope System articulated tip. To evaluate the events of device deficiency and/or malfunctions of SIRIUS Endoscope System. To evaluate the Safety of SIRIUS Endoscope System
Description
To assess the effectiveness of the bending function of the SIRIUS endoscope system by capturing the amount of time the SIRIUS endoscope is bent or straightened during the operation.
Time Frame
Data will be collected during the operation and it will be completed upon the completion of the operation

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women-only
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Eligible women, 18 or older, who are planned for laparoscopic gynaecological surgery and willing to provide informed consent prior to surgery Exclusion Criteria: Patient is pregnant, or planning on becoming pregnant Obese patients (BMI >35) Patient with known contraindication(s) to Laparoscopic Gynecological Surgery Patient with operations planned for longer than 4 hours Subjects are considered ineligible for the study as judged by the investigator.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Benny Lo, PhD
Phone
+852 64785586
Email
b.lo@precisionrobotics.com
First Name & Middle Initial & Last Name or Official Title & Degree
Ruchita Mehta, MS
Phone
+852 70734437
Email
R.Mehta@precisionrobotics.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tong Yow Ng, MD
Organizational Affiliation
Gleneagles Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gleneagles Hospital Hong Kong
City
Wong Chuk Hang
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tong Yow Ng, Dr.

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35321072
Citation
Ng TY, Ngu SF, Kam TYD, Ng SY, Lo PLB. First in-human trial and prospective case series of an articulated laparoscopic camera system in minimally invasive surgery in gynecology: an IDEAL stage 1 and 2a study. BMJ Surg Interv Health Technol. 2022 Mar 4;4(1):e000117. doi: 10.1136/bmjsit-2021-000117. eCollection 2022.
Results Reference
derived

Learn more about this trial

Sirius in Gynaecological Laparoscopic Surgery

We'll reach out to this number within 24 hrs